Talk Bio

Scholar Rock wins FDA approval for ISEMBYLD SMA therapy after year-long manufacturing delay

Incyte Receives FDA CRL for Zynyz NSCLC Expansion Due to Issues at Novo Nordisk's Catalent Indiana Facility, Becoming Third Affected Company

FDA Rejects Scholar Rock's SMA Drug Due to Catalent Indiana Manufacturing Issues